RETRACTED: Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways (Retracted Article)

被引:64
作者
Bischof, O [1 ]
Nacerddine, K [1 ]
Dejean, A [1 ]
机构
[1] Inst Pasteur, INSERM, U579, Nucl Org & Oncogenesis Unit, F-75724 Paris 15, France
关键词
D O I
10.1128/MCB.25.3.1013-1024.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular senescence can be triggered by a variety of signals. including loss of telomeric integrity or intense oncogenic signaling, and is considered a potent, natural tumor suppressor mechanism. Previously, it was shown that the promyelocytic leukemia protein (PML) induces cellular senescence when overexpressed in primary human fibroblasts. The mechanism by which the PML W isoform elicits this irreversible growth arrest is believed to involve activation of the tumor suppressor pathways p21/p53 and p16/Rb: however. a requirement for either pathway has not been demonstrated unequivocally. To investigate the individual contributions of p53 and Rb to PML-induced senescence, we used oncoproteins E6 and E7 from human papillomaviruses (HPVs). which predominantly target p53 and Rb. We show that E7, but not E6, circumvents PML-induced senescence. Using different E7 mutant proteins, dominant negative cyclin-dependent kinase 4, and p16 RNA interference. we demonstrate that Rb-related and Rb-independent mechanisms of E7 are necessary for subversion of PML-induced senescence and we identify PML as a novel target for E7. Interaction between E7 and a functional prosenescence complex composed of PML, p53, and CBP perturbs transcriptional activation of p53. thus highlighting a significant effect also on the p53 tumor suppressor pathway. Given the importance of HPV in the pathogenesis of cervical cancer, our results warrant a more detailed analyses of PML in HPV infections.
引用
收藏
页码:1013 / 1024
页数:12
相关论文
共 66 条
[1]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[2]   Interaction of the HPV E7 proteins with the pCAF acetyltransferase [J].
Avvakumov, N ;
Torchia, J ;
Mymryk, JS .
ONCOGENE, 2003, 22 (25) :3833-3841
[3]  
BARTKOVA J, 1995, CANCER RES, V55, P949
[4]   Interaction between the HPV E7 oneoprotein and the transcriptional coactivator p300 [J].
Bernat, A ;
Avvakumov, N ;
Mymryk, JS ;
Banks, L .
ONCOGENE, 2003, 22 (39) :7871-7881
[5]   Deconstructing PML-induced premature senescence [J].
Bischof, O ;
Kirsh, O ;
Pearson, M ;
Itahana, K ;
Pelicci, PG ;
Dejean, A .
EMBO JOURNAL, 2002, 21 (13) :3358-3369
[6]  
Boyer SN, 1996, CANCER RES, V56, P4620
[7]   The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth [J].
Brehm, A ;
Nielsen, SJ ;
Miska, EA ;
McCance, DJ ;
Reid, JL ;
Bannister, AJ ;
Kouzarides, T .
EMBO JOURNAL, 1999, 18 (09) :2449-2458
[8]   Tumor suppressors and oncogenes in cellular senescence [J].
Bringold, F ;
Serrano, M .
EXPERIMENTAL GERONTOLOGY, 2000, 35 (03) :317-329
[9]   Cellular senescence as a tumor-suppressor mechanism [J].
Campisi, J .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S27-S31
[10]   Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein [J].
Chelbi-Alix, MK ;
Quignon, F ;
Pelicano, L ;
Koken, MHM ;
De Thé, H .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1043-1051